Reported in several places yesterday:
“ Insulet said it plans to pause a pivotal clinical study of its upcoming wearable insulin pump due to an anomaly in the device’s software.
The company said the computer bug could cause the automated Omnipod Horizon diabetes system to use an incorrect blood glucose value in its calculations for a person’s insulin delivery. No adverse events have been reported due to the issue, which Insulet described as a rare occurrence.
Insulet said it plans to deliver a software update to correct the problem by the end of April. It also expects the temporary hold to push back the Omnipod Horizon’s market release, now slated for early 2021 instead of the second half of 2020.“